You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

3rd line

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

3rd Line Therapy or More to Treat Adult CML- CP in Real World

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Oct 16, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Y-90 SIR-Spheres
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 7, 2022

Non Small Cell Lung Cancer Trial in Goyang-si (IP, GP)

Completed
  • Non Small Cell Lung Cancer
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center, Korea
Apr 4, 2022

Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)

Recruiting
  • Brain Metastases
  • Non-small Cell Lung Cancer
  • EGFR-TK Inhibitor
  • Stereotactic radiotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 27, 2023

Learn More About Order of Different Treatments and Their Effects

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • (no location specified)
Nov 13, 2023

Esophageal Squamous Cell Carcinoma Trial (Combination (S095033 + paclitaxel))

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Combination (S095033 + paclitaxel)
  • (no location specified)
Mar 28, 2022

Leiomyosarcoma Trial in Santa Monica (Trabectedin)

Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
    Sant P Chawla
Oct 13, 2022

Metastatic NSCLC, NSCLC, Lung Cancer Trial in United States (Trilaciclib, Placebo, Docetaxel)

Terminated
  • Metastatic Non-Small Cell Lung Cancer
  • +2 more
  • Phoenix, Arizona
  • +11 more
Feb 11, 2022

3rd Line GIST Trial in Worldwide (ST571 + BYL719)

Completed
  • 3rd Line GIST
  • ST571 + BYL719
  • Portland, Oregon
  • +10 more
Dec 17, 2020

3rd Line GIST Trial in Worldwide (STI571, BKM120)

Completed
  • 3rd Line GIST
  • Boston, Massachusetts
  • +10 more
Dec 17, 2020

Colorectal Cancer, Colorectal Cancer Metastatic Trial in United States (Pembrolizumab, Regorafenib)

Active, not recruiting
  • Colorectal Cancer
  • Colorectal Cancer Metastatic
  • Duarte, California
  • +3 more
Aug 5, 2022

Pancreatic Cancer Stage IV Trial in United States (CBP501 (16), CBP501 (25), Cisplatin)

Active, not recruiting
  • Pancreatic Cancer Stage IV
  • CBP501 (16)
  • +3 more
  • Tucson, Arizona
  • +19 more
Aug 16, 2022

Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

Recruiting
  • Chronic Myelogenous Leukemia
  • ABL001 40mg BID
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +53 more
Jan 27, 2023

Followed by 3rd Generation EGFR-TKI in EGFR Mutation Positive

Recruiting
  • EGFR Activating Mutation
  • +3 more
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 23, 2021

Ovarian Cancer Trial in Germany (Standard chemo, Romiplostim, Placebos)

Terminated
  • Ovarian Cancer
  • Standard chemotherapy
  • +2 more
  • Berlin, Germany
  • +12 more
Feb 3, 2021

Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression

Completed
  • Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression
  • JAK expression
  • Mansoura, Egypt
    Mansoura University Hospital
Dec 9, 2020

Immunotherapy, Second-line Treatment Trial in Guizhou (Cadonilimab)

Recruiting
  • Immunotherapy
  • Second-line Treatment
  • Guizhou, ZunYi, China
    The Second Affiliated Hospital of Zunyi Medical University
Jun 14, 2023

Immunization, Efficacy, Human Papilloma Virus Trial in Galveston (9-valent HPV vaccine, 2 dose efficacy, 9-valent HPV vaccine, 3

Recruiting
  • Immunization
  • +2 more
  • 9-valent HPV vaccine, 2 dose efficacy
  • 9-valent HPV vaccine, 3 doses standard timing
  • Galveston, Texas
    University of Texas Medical Branch
Jan 30, 2023

Mesothelioma Trial in France (Nivolumab, Nivolumab + Ipilimumab)

Completed
  • Mesothelioma
  • Angers, France
  • +21 more
Feb 9, 2021

Colorectal Cancer Trial in Guangzhou, Shanghai (fruquintinib)

Completed
  • Colorectal Cancer
  • Guangzhou, Guangdong, China
  • +1 more
Feb 13, 2020

Carcinoma, Small Cell Lung Trial in United States (RRx-001 + eLOOP Device, Cisplatin/carboplatin plus etoposide)

Active, not recruiting
  • Carcinoma, Small Cell Lung
  • RRx-001 + eLOOP Device
  • Cisplatin/carboplatin plus etoposide
  • Tampa, Florida
  • +5 more
Oct 3, 2022

Essential Hypertension Trial in Seoul (L04RD1, L04TD3)

Completed
  • Essential Hypertension
  • Seoul, Korea, Republic of
    H plus Yangji Hospital
Aug 7, 2023

Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)

Active, not recruiting
  • Neuroblastoma
  • iC9-GD2 T Cells - frozen
  • +5 more
  • Houston, Texas
  • +1 more
Jan 4, 2023

Gaucher Disease, Type 3 Trial (Gene therapy, Enzyme Replacement Agent)

Not yet recruiting
  • Gaucher Disease, Type 3
  • Gene therapy
  • Enzyme Replacement Agent
  • (no location specified)
Apr 14, 2023

Healthy Aging, Healthy Lifestyle, Healthy Diet Trial (1. Nutrition; 2. Physical activity; 3. Hypoxic training; 4. Menthal heals

Recruiting
  • Healthy Aging
  • +2 more
  • 1. Nutrition; 2. Physical activity; 3. Hypoxic training; 4. Menthal heals improvement
  • Saint Petersburg, Russian Federation
    First Line Health Care Resort
Oct 28, 2022